(S)-3-methoxy-4-(1-(3-(2-methyl-1H-imidazol-1-yl)phenoxy)propan-2-yloxy)benzonitrile

ID: ALA4583704

PubChem CID: 138471365

Max Phase: Preclinical

Molecular Formula: C21H21N3O3

Molecular Weight: 363.42

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C#N)ccc1O[C@@H](C)COc1cccc(-n2ccnc2C)c1

Standard InChI:  InChI=1S/C21H21N3O3/c1-15(27-20-8-7-17(13-22)11-21(20)25-3)14-26-19-6-4-5-18(12-19)24-10-9-23-16(24)2/h4-12,15H,14H2,1-3H3/t15-/m0/s1

Standard InChI Key:  SILCBNWSDQDKBJ-HNNXBMFYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   29.9499  -11.2425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9487  -12.0621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6568  -12.4710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3664  -12.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3636  -11.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6550  -10.8337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0698  -10.8277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.7790  -11.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4852  -10.8223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1944  -11.2283    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.9006  -10.8170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6058  -11.2247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3115  -10.8141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3089   -9.9960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5947   -9.5903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8919  -10.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2461  -10.8299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1604  -10.0172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3611   -9.8475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9526  -10.5553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4996  -11.1624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3300  -11.9618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0151   -9.5882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7207   -9.1760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.4821  -10.0052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6070  -12.0419    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.8999  -12.4515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
  1 17  1  0
 21 22  1  0
 23 24  3  0
 14 23  1  0
  9 25  1  6
 12 26  1  0
 26 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4583704

    ---

Associated Targets(Human)

ICMT Tchem Isoprenylcysteine carboxyl methyltransferase (596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.42Molecular Weight (Monoisotopic): 363.1583AlogP: 3.91#Rotatable Bonds: 7
Polar Surface Area: 69.30Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.64CX LogP: 3.46CX LogD: 3.40
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.64Np Likeness Score: -1.70

References

1. Kargbo RB..  (2019)  Treatment of Cancers by Inhibition of Isoprenylcysteine Carboxyl Methyltransferase.,  10  (7): [PMID:31312402] [10.1021/acsmedchemlett.9b00269]

Source